SCHEMBL3228170

SCHEMBL3228170

O=C(O)[C@H]1CCC[C@H]1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3228177 1.00
SCHEMBL6559471 1.00
SCHEMBL2692497 1.00
SCHEMBL2693338 1.00
SCHEMBL2034245 1.00
SCHEMBL5897097 1.00
SCHEMBL5897084 1.00
Water SCHEMBL16700845 0.97 PEPD (0.45)
SCHEMBL3339166 0.94 MEN1 (0.43)
SCHEMBL5897163 0.94 MEN1 (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025101892-A1 POLY-ADP RIBOSE POLYMERASE (PARP) INHIBITORS AND USES THEREOF Astellas Engineered Small Molecules US, Incorporated (US) 2025-05-15 WO disclosed
EP-3418282-A1 TRICYCLIC COMPOUND SERVING AS IMMUNOMODULATOR Chai Tai Tianqing Pharmaceutical Group Co., Ltd. (CN) 2018-12-26 EP disclosed
WO-2010015588-A1 BENZYL-SUBSTITUTED TETRACYCLIC HETEROCYCLIC COMPOUNDS NYCOMED GMBH (DE) 2010-02-11 WO disclosed
US-7358250-B2 Pyrrolo[2,3-d]pyrimidines that modulate ACK1 activity AMGEN INC. (US) 2008-04-15 US disclosed
US-20060040965-A1 Pyrrolo[2,3-d]pyrimidines that modulate ACK1 activity AMGEN INC. 2006-02-23 US disclosed